{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:21:30Z","timestamp":1776129690492,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00277-017-2918-9","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T10:33:06Z","timestamp":1484303586000},"page":"581-587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection"],"prefix":"10.1007","volume":"96","author":[{"given":"Miao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tienan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huacong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"2918_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/asheducation-2013.1.76","volume":"2013","author":"NS Young","year":"2013","unstructured":"Young NS (2013) Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program 2013:76\u201381","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2918_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","volume":"147","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Ball SE, Cavenagh J et al (2009) Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147(1):43\u201370","journal-title":"Br J Haematol"},{"issue":"3","key":"2918_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2893.2004.00515.x","volume":"11","author":"MS Dai","year":"2004","unstructured":"Dai MS, Kao WY, Shyu RY et al (2004) Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia. J Viral Hepat 11(3):283\u2013285","journal-title":"J Viral Hepat"},{"issue":"11\u201312","key":"2918_CR4","first-page":"697","volume":"58","author":"W Luczy\u0144ski","year":"2005","unstructured":"Luczy\u0144ski W, Muszy\u0144ska-Ros\u0142an K, Krawczuk-Rybak M et al (2005) Immunotherapy in aplastic anaemia as a cause of reactivation of hepatitis B virus-immunologic aspects. Wiad Lek 58(11\u201312):697\u2013699","journal-title":"Wiad Lek"},{"key":"2918_CR5","first-page":"81","volume":"140","author":"J Ehrmann Jr","year":"1996","unstructured":"Ehrmann J Jr, Kucerova L, Jezdinsk\u00e1 V et al (1996) Fulminant hepatitis caused by a hepatitis B virus infection in the patients with haematologic malignancies. Report of 5 cases. Acta Univ Palacki Olomuc Fac Med 140:81\u201382","journal-title":"Acta Univ Palacki Olomuc Fac Med"},{"issue":"5","key":"2918_CR6","first-page":"360","volume":"21","author":"T Ohtsu","year":"1991","unstructured":"Ohtsu T, Sai T, Oka M et al (1991) Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies. Jpn J Clin Oncol 21(5):360\u2013365","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"2918_CR7","first-page":"333","volume":"25","author":"MF Tu","year":"2005","unstructured":"Tu MF, Shao ZH, Liu H et al (2005) The clinical features of severe aplastic anemia patients with chronic hepatitis B virus infection. Chinese Journal of Practical Internal Medicine 25(4):333\u2013335","journal-title":"Chinese Journal of Practical Internal Medicine"},{"key":"2918_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2147\/DDDT.S67908","volume":"8","author":"HF Chen","year":"2014","unstructured":"Chen HF, Xu BX, Shen HS et al (2014) Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia. Drug Des Devel Ther 8:1299\u20131305","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"2918_CR9","first-page":"310","volume":"20","author":"YD Wang","year":"2012","unstructured":"Wang YD, Fan CC, Zhao CY et al (2012) Clinical features of aplastic anemia patients with hepatitis B virus infection: a case report of 12 patients. Zhonghua Gan Zang Bing Za Zhi 20(4):310\u2013311","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"2918_CR10","first-page":"283","volume":"25","author":"Y Lu","year":"2011","unstructured":"Lu Y, Zhang YL, Shen G et al (2011) Clinical study on viral hepatitis combined with aplastic anemia. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 25(4):283\u2013285","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"issue":"1","key":"2918_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association For The Study Of The Liver","year":"2012","unstructured":"European Association For The Study Of The Liver (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57(1):167\u2013185","journal-title":"J Hepatol"},{"issue":"3","key":"2918_CR12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood.V53.3.504.504","volume":"53","author":"BM Camitta","year":"1979","unstructured":"Camitta BM, Thomas ED, Nathan DG et al (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53(3):504\u2013514","journal-title":"Blood"},{"issue":"9","key":"2918_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","volume":"289","author":"S Rosenfeld","year":"2003","unstructured":"Rosenfeld S, Follmann D, Nunez O et al (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130\u20131135","journal-title":"JAMA"},{"issue":"1","key":"2918_CR14","first-page":"75","volume":"31","author":"RS Chong","year":"1990","unstructured":"Chong RS, Ng HS, Ong YY et al (1990) A case of aplastic anaemia associated with fulminant hepatitis B. Singap Med J 31(1):75\u201377","journal-title":"Singap Med J"},{"key":"2918_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0002-9343(88)80356-5","volume":"85","author":"PA McSweeney","year":"1988","unstructured":"McSweeney PA, Carter JM, Green GJ et al (1988) Fatal aplastic anemia associated with hepatitis B viral infection. Am J Med 85:255\u2013256","journal-title":"Am J Med"},{"issue":"4","key":"2918_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2006.11.023","volume":"46","author":"E Cariani","year":"2007","unstructured":"Cariani E, Pelizzari AM, Rodella A et al (2007) Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays. J Hepatol 46(4):743\u2013747","journal-title":"J Hepatol"},{"issue":"8","key":"2918_CR17","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1023\/A:1016444611997","volume":"47","author":"H Bozkaya","year":"2002","unstructured":"Bozkaya H, Yurdaydin C, T\u00f6r\u00fcner M et al (2002) Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine. Dig Dis Sci 47(8):1782\u20131785","journal-title":"Dig Dis Sci"},{"issue":"11\u201312","key":"2918_CR18","first-page":"1123","volume":"88","author":"CK Lin","year":"1989","unstructured":"Lin CK, Gau JP, Ho CH et al (1989) Aplastic anemia in Taiwan and its etiological factors. Taiwan Yi Xue Hui Za Zhi 88(11\u201312):1123\u20131127","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"issue":"5","key":"2918_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/hep.510250532","volume":"25","author":"S Issaragrisil","year":"1997","unstructured":"Issaragrisil S, Kaufman D, Thongput A et al (1997) Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand. Hepatology 25(5):1255\u20131257","journal-title":"Hepatology"},{"issue":"42","key":"2918_CR20","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3748\/wjg.v21.i42.11941","volume":"21","author":"R Zampino","year":"2015","unstructured":"Zampino R, Boemio A, Sagnelli C et al (2015) Hepatitis B virus burden in developing countries. World J Gastroenterol 21(42):11941\u201311953","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2918_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.autrev.2008.07.016","volume":"8","author":"P Patrizia","year":"2008","unstructured":"Patrizia P, Laura V, Santina Q et al (2008) Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev 8(1):13\u201317","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2918_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM et al (2016) AASLD guidelines for treatment of chronic hepatitis B. Hepatology 63(1):261\u2013283","journal-title":"Hepatology"},{"issue":"4","key":"2918_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000321790","volume":"124","author":"H Bing","year":"2010","unstructured":"Bing H, Siyi Y, Wei Z et al (2010) The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine a to treat patients with acquired severe aplastic anemia. Acta Haematol 124(4):245\u2013250","journal-title":"Acta Haematol"},{"issue":"3","key":"2918_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ejh.12590","volume":"96","author":"M Chen","year":"2016","unstructured":"Chen M, Liu C, Zhuang JL et al (2016) Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia. Eur J Haematol 96(3):291\u2013296","journal-title":"Eur J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2918-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-017-2918-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2918-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:33:10Z","timestamp":1659058390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-017-2918-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-2918-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"assertion":[{"value":"2 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the Ethics Committee of Peking Union Medical College Hospital and with the Helsinki Declaration of 1975, as revised in 2008. Patient information was anonymized and de-identified prior to analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}